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Abstract
This review attempted to evaluate the exposure of thermal processing contami-
nants such as furan, chloropropanols and acrylamide from infant formulas. Furan, 
chloropropanols and acrylamide exist at varying levels in several types of foods that 
are consumed in daily diet including infant formulas. The consumption of these 
foods leads to the exposure to the thermal processing contaminants. In this sense, it 
is apparent that humans face hidden danger through dietary exposure throughout 
their lives. Infants are considered as the age group that expose to the highest levels 
of these substances as a result of the fact that they have low body weight and con-
sume infant formulas in their diets as alternative nutrition. The review emphasizes 
that the infant formulas are not innocent, on the contrary, they can be considered as 
safety critical for infants considering that infant formulas include furan, chloropro-
panols and acrylamide. Therefore, this review suggests that in this sense all share-
holders’ (university, non-governmental organizations, public and private sector) 
acting in concert with each other is crucially important for the health of individuals 
and overall society.
Keywords: infant formulas, furan, chloropropanols, 3-MCPD, 2-MCPD, glycidol, 
acrylamide, exposure
1. Introduction
World Health Organization (WHO) and UNICEF advices that infants need to 
be exclusively breasted for the first 6 months and breastfeeding should last mini-
mum 2 years. Nevertheless, around the world, the rate of breastfeeding in the first 
6 months is still 38% and this percentage has not changed for about 20 years. It is 
known that breast milk significantly contributes to infants’ physical and mental 
development and acts as a protector for infants against several diseases. Therefore, 
with the contributions of WHO and UNICEF, breast milk is being promoted in 
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order to increase the rate of breastfeeding to 50% for the first 6 months until 2025 
and studies are being carried out with regard to the importance of breast feeding in 
early periods of infancy [1, 2].
Use of breast feeding as primary nutrition in early periods, namely in the first 
6 months, of infancy is highly common around the world (Norway: 95%, Australia: 
92%, Canada: 89%, United States: 77%) and the percentage increases gradually 
year by year. On the contrary, after 6 months is decreasing dramatically [3]. By 
all means, there are several factors affecting this case. Some of these factors are 
mothers’ becoming a mother young, not having breastfeeding experience, concern 
of insufficient breast milk, desire to feed their babies with new tastes, active work 
life, long working hours and perceptions of mothers created by other individuals, 
mother’s and baby’s health condition, babies’ becoming acquainted with pacifier 
and feeding bottle [4–6]. Besides these factors, depending on the development of 
the baby, mothers generally give their babies other nourishments as supplement to 
breast milk or use them as only source of nutrition for their babies. The top of these 
nourishments is infant formulas.
There are several firms operating globally in the sector of infant formulas which 
has become a massive market today. These firms invest in research-development 
activities, advertising activities and develop marketing strategies in order to gain 
advantage in the competition [7]. It is easy to find several follow-on milk, follow-on 
formulas and mixed formulas for the needs of 0–6 months-old and >6 months-
old babies, which are formulated either in powder or liquid form and enriched 
with various ingredients [8]. Infant formulas are often preferred in that they are 
accessible and easy to prepare; besides, they can be used by others when mother is 
not available for feeding. On the other hand, it is known that mothers are deeply 
anxious about the infant formulas although they try to make their best to choose the 
most appropriate formula for their babies based on their research on written and 
visual media, advices from others and past experiences [9, 10].
On one hand, it is beyond argument that breast milk is the best choice for babies’ 
nourishment, development and health; on the other hand, it is not always the one 
and only choice because of various reasons. Therefore, it needs to be ensured that 
the adverse effects of infant formulas, which are used as supplement to breast milk 
or used exclusively, on babies’ health in the short-, medium- and long-term are 
eliminated and these formulas not to cause any health problems for babies. In this 
respect, certain legal regulations are designed for the production and marketing 
of infant formulas nationally and globally. However, in the literature, although 
infant formulas carry the risk with respect to furan, acrylamide, chloropropanols 
and polycyclic aromatic hydrocarbons, which are called thermal processing con-
taminants and have potential to cause various health problems for humans, this 
information has not been referred in the legal regulations. Considering that the 
contaminants in question are included in various foods that are frequently preferred 
in daily diets, individuals expose to these contaminants starting from very early 
periods of infancy and this exposure continues throughout their lives. To this end, 
the current review aims to evaluate the infant formulas with respect to certain 
thermal processing contaminants.
2. Thermal process contaminants
Besides bringing certain sensorial properties to foods, thermal process is a 
processing technique that eliminates or decreases the potential hazards originating 
from foods against consumers’ health through making foods microbiologically more 
reliable. However, under certain conditions thermal processing applications cause 
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certain toxic substances called “thermal processing contaminants” (heterocyclic 
aromatic amines, 5-hydroxymethylfurfural, polycyclic aromatic hydrocarbons, 
nitrosamines, furan, acrylamide, and chloropropanols) to emerge [11, 12]. In the 
last 10 years, a great amount of research has focused on thermal processing contam-
inants and this topic is still current and important for consumers, health authorities 
and industries [13].
2.1 Furan
Furan is colorless, highly volatile and flammable compound with a boiling point 
close to room temperature (≈31°C). It is soluble in most of the organic solvents such 
as alcohol and acetone. Furan with a molecular formula of C4H4O and CAS number 
of 110-00-9 is a heterocyclic and aromatic compound [14].
Formation of furan in foods is the result of various mechanisms. It has been 
documented that besides the presence of reducing sugar or amino acids, thermal 
degradation or Maillard reaction, ascorbic acid, thermal oxidation, oxidized poly-
unsaturated lipids, serine and cysteine without other sources [15, 16].
In the risk assessment undertaken by U.S. National Institutes of Health (NIH) 
and Joint FAO/WHO Expert Committee on Food Additives (JECFA) depending on 
the studies on laboratory animals, furan was reported to be a strong carcinogenic 
compound that affected several organs [17, 18]. It has been identified as “possibly 
carcinogen to humans” (Group 2B) by International Agency for Research on Cancer 
(IARC) [19].
In a study conducted by The US Food and Drug Administration (FDA) in year 
2004 with 334 foodstuffs, presence of furan was reported for canned and jarred 
baby foods, infant formulas, coffees, meats, fish, soups, sauces, vegetables and 
fruits and several other foodstuffs that underwent thermal processing. Particularly, 
the study reported that all baby foods included furan [20]. After FD reports, The 
European Commission Recommendation 2007/196/EC offered a suggestion to 
the member countries in order for tracking the toxicity, formation, analysis and the 
exposure of furan [21]. Based on the reports from several countries, JECFA reported 
the foodstuffs that included the highest furan levels; roasted coffee (powder) 
(814–4590 μg/kg), instant coffee (powder) (90–783 μg/kg), brewed roasted cof-
fee (34–113 μg/kg), baby food (19–96 μg/kg), soya sauce (16–52 μg/kg), canned 
fish (6–76 μg/kg) and baked beans (27–581 μg/kg) [22]. According to the reports of 
European Food Safety Authority (EFSA) and FDA, Crews and Castle classified the 
foodstuffs in three categories that included furan more than 100 μg/kg; coffee,  
baby foods, sauces and soups. Moreover, furan was found in 262 of 273 baby 
foods, 70 of 71 infant foods, 28 of 42 infant formulas. The levels of furan in baby 
foods, infant foods and infant formulas change between the ranges of 1–112 μg/kg 
(mean: 28 μg/kg), 1.3–87.3 μg/kg (mean: 27 μg/kg) and 2.5–27 μg/kg (mean: 12 μg/kg), 
respectively [23]. Several studies reported different levels of furan in baby foods and 
infant formulas; EFSA 31–32, 0.2–3.2 μg/kg, Liu and Tsai 4.23–124.1, 2.4–28.7 μg/kg 
[24, 25]. Lambert et al. determined the furan levels of many foods including baby 
foods and infant formulas (Table 1) [26].
In this respect, Table 2 displays the results of dietary exposure of furan in 
individuals from diverse group of ages reported by EFSA.
The mean of infants’ dietary exposure of furan was reported as 0.99–1.34 μg/
kg bw per day by FAO/WHO whereas Health Canada reported this level as 1.76 μg/
kg bw per day [17, 28]. Some studies reported the mean of dietary exposure of furan 
for 4 months, 5–6 months, 7–12 months and 13–36 months old infants as 0.14, 0.60, 
0.84 and 0.37 μg/kg bw per day [29] and 0.09, 0.56, 0.80 and 0.33 μg/kg bw per 
day, respectively [30].
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2.2 Chloropropanols
In recent years, the presence of chloropropanols (certain fatty acid esters of 
3-monochloro-1,2-propanediol (3-MCPD) and the related substance glycidol, 
2-monochloro-1,3-propanediol (2-MCPD), 1,3-dichloro-2-propanol (1,3-DCP) 
and 2,3-dichloro-1-propanol (2,3-DCP)) in foodstuffs has aroused the attention 
of researchers [31]. Dichloropropanols are comprised of monoesters whereas 
monochloropropanediols are comprised of both monoesters and diesters [32]. It has 
been estimated that depending on thermal processing, lipids, glycerol, triolein and 
lecithin that are heated with hydrochloric acid are precursors in the formation of 
chloropropanols in foodstuffs [33, 34]. Chloropropanols and its esters are created 
from lipids and chlorides in the oil refining process particularly when the deodor-
ization process is realized under high temperatures. Moreover, glycidol can occur 
through dehalogenation from 3-MCPD [35].
It has not been ascertained that whether chloropropanol is a carcinogenic 
compound. On the other hand, it is disturbing that some free chloropropanol forms 
in foodstuffs are potentially toxic. The JECFA reported that 1,3-DCP is a genotoxic 
carcinogen, however, there is not enough evidence for the toxicologic evaluation of 
2-MCPD [36, 37]. In this respect, Lee and Khor found that 3-MCPD and 1,3-DCP 
have potential genotoxic and carcinogenic characteristics [38]. Similarly, Onami 
Age group Mean dietary exposure  
(μg/kg bw per day)
High dietary exposure  
(μg/kg bw per day)
Infants 0.14–0.99 0.27–1.82
Toddlers 0.22–0.65 0.05–0.31
Other children 0.19–0.52 0.29–0.86
Adolescents 0.11–0.54 0.20–1.22
Adults 0.03–0.59 0.08–1.29
Elderly 0.12–0.61 0.24–1.27
Very elderly 0.13–0.75 0.27–0.96
*The data were taken directly from EFSA Journal.
Table 2. 
Dietary exposure of furan [27].
Food group Mean (μg/kg)
Baby foods 3.3–41
Infant formulae 3.5–5.7
Vegetables 5.9–6.3
Fish 5.3–5.3
Cereal products 44–44
Meat products 7.3–7.5
Milk products 1.4–2.3
Soups 16–16
*The data were taken directly from Lambert et al.
Table 1. 
The mean level of furan in different food groups [26].
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et al. suggested that 3-MCPD carries unignorable risks for human health with 
regard to its potential hazard [39]. In some other studies 1,3-DCP and 3-MCPD are 
defined as possible human carcinogens (group 2B) and similarly glycidol is referred 
as a probable human carcinogen (group 2A) [40–42]. One of the most comprehen-
sive studies on the toxicologic evaluation of chloropropanols revealed that whereas 
the carcinogenic effect of 1,3-DCP was highly evident, for the reason that the level 
of its presence in foodstuffs was considerably low, 1,3-DCP did not carry a risk 
for human health. This comprehensive study emphasized the insufficiency of the 
research on the level of the presence of 2-MCPD and 2,3-DCP in foodstuffs and the 
toxicologic evaluation of these substances. However, current evidence suggests that 
these compounds can be considered within low risk group for human health for the 
reason that the level of the presence of these compounds in foodstuffs is low [43]. 
EFSA determined the tolerable daily intake (TDI) for 3-MCPD as 0.8 μg/kg bw 
per day, whereas JECFA suggested the provisional maximum tolerable daily intake 
(PMTDI) of 4 μg/kg bw/day [44, 45].
Recent studies revealed that chloropropanols was found in several foodstuffs 
at different levels particularly in soy sauces, meat and meat products, fish and sea 
foods, cereals, snacks, bread, biscuits, crisps, chips, baby foods and infant formulas 
as well [46, 47]. Table 3 shows the levels of chloropropanols in foodstuffs reported 
in the comprehensive study by EFSA.
Considering the other studies on infant formulas and chloropropanols, 
Zelinková et al. identified 3-MCPD as 1.04–2.03 mg/kg, Weißhaar identified 
glycidol as 2.6–5.3 mg/kg, and Wöhrlin et al. identified 3-MCPD as 0.42 mg/kg and 
2-MCPD, 0.19 mg/kg, glycidol 0.36 mg/kg [49–51]. Table 4 displays the results sug-
gested by EFSA regarding the dietary exposure of chloropropanols for the individu-
als from different age groups.
EFSA revealed that the food group that contributes 50% and higher levels 
of 3-MCPD, 2-MCPD and glycidol exposure for infants is infant formulas and 
follow-on formulas, which are followed by vegetable fats and oils, besides cook-
ies. The levels of 3-MCPD, 2-MCPD and glycidol considering the exposure from 
only infant formulas were calculated as 2.4, 0.7–1.3, and 1.8–2.1 μg/kg bw per day, 
respectively [48]. JECFA estimated the average exposure to glycidol equivalents for 
babies between 0.1 and 3.6 μg/kg bw/day. However, the exposure level of 3-MCPD 
equivalents can increase to 10 μg/kg bw/day on average for the babies that are fed 
by infant formulas in the early periods of their lives [45]. Spungen et al. estimated 
the exposure of 3-MCPD equivalents for 0–1, 2–3 and 5–6 months old babies as 10, 
Food groups 3-MCPD μg/kg 2-MCPD μg/kg Glycidol μg/kg
Vegetable fats and oils 1093 (1090–1095) 414 (400–427) 1268 (1259–1277)
Margarine and similar products 408 (406–409) 159 (152–166) 361 (358–364)
Infant formulas (powder) 108 (108–109) 44 (31–58) 87 (80–94)
Cereal-based products and similar 83 (77–90) 42 (38–47) 51 (50–51)
Fried, baked or roast meat or fish 
products
30 (26–34) 10 (7–14) 38 (38–39)
Smoked meat or fish products 21 (15–28) 6.2 (0.5–11) 17 (15–19)
Snacks and potato products 130 (123–137) 79 (75–84) 58 (58–59)
*The data were taken directly from EFSA Journal.
Table 3. 
The mean level of 3-MCPD, 2-MCPD, glycidol and esters in different food groups [48].
Infant Feeding - Breast versus Formula
6
8, 7 μg/kg bw per day respectively, whereas the exposure of glycidol and esters were 
estimated 2 μg/kg bw per day and same for all age groups [52]. Arisseto et al. identi-
fied the exposure of 3-MCPD for.
0–5, 6–11 months old babies as 2.49, 1.05 μg/kg bw/day, respectively and the 
glycidol exposure as 3.65, 1.64 μg/kg bw/day [53].
2.3 Acrylamide
Acrylamide (AA), which was identified for the first time as a chemical compound 
in 1893 in Germany, is a chemical agent used extensively in such sectors as dams, tun-
nels, water treatment, paper and textile [54]. The presence of AA in foods for the first 
time was identified in 2002 by a group of researchers in Sweden [55]. Acrylamide 
formation in foods is explained through several mechanisms. The most important of 
all these mechanisms is especially Maillard reaction, which is performed in thermal 
processing with the presence of asparagines amino acid and reducing sugar [56]. It 
has been revealed that, apart from this mechanism, acrolein, B-alanine, aspartic acid, 
pyruvic acid and carnosine cause AA formation through various reactions [57].
In the experimental studies carried out with animals, a positive dose-response 
relationship between AA and the cancer in multi-organs and tissues was found 
[58, 59]. In epidemiological studies conducted with humans, it was suggested that 
AA could seriously affect fetal development [60] and neurological changes [61]. 
On the other hand, there is not a clear consensus on the relationship between AA 
and cancer yet. Whereas, some studies reveal that AA increases the risk of contract-
ing ovarian cancer [62], lung cancer [63] and the cancers related to digestive and 
respiratory systems [64], some other studies determine that AA has no positive 
relationship with several types of cancer [65–67]. However, IARC classifies AA as a 
probable human carcinogen (group 2A) [68].
EFSA reported the results of the study that show AA levels in several foodstuffs 
in 2015 (Table 5).
In the other studies on infant formulas, different acrylamide levels were 
reported; Fohgelberg et al. found 3.5–223 μg/kg and Elias et al. found <LOD (limit 
of detection)-353 μg/kg [70, 71]. Likewise, Table 6 displays the results of dietary 
AA exposure of the individuals from different age groups reported by EFSA.
Mojska et al. calculated the daily dietary intake of acrylamide for 6, 7, 8, 9 and 
10–12 months old babies as 17.46, 20.87, 21.65, 29.06 and 38.05 μg/person/day, 
respectively [72]. Considering the other studies on AA exposure, Health  
Canada estimated the AA exposure for <1 years and 1–3 years old babies as  
Age group 3-MCPD
μg/kg bw per day
2-MCPD
μg/kg bw per day
Glycidol
μg/kg bw per day
Infants 0.5–1.0 0.2–0.4 0.4–0.8
Toddlers 0.6–1.4 0.3–0.6 0.4–0.9
Other children 0.5–1.5 0.3–0.7 0.3–0.9
Adolescents 0.2–0.7 0.1–0.3 0.2–0.5
Adults 0.2–0.4 0.1–0.2 0.2–0.3
Elderly 0.2–0.4 0.1–0.2 0.1–0.3
Very elderly 0.2–0.5 0.1–0.2 0.1–0.3
*The data were taken directly from EFSA Journal.
Table 4. 
The mean of the dietary exposure to 3-MCPD, 2-MCPD and Glycidol [48].
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0.211, 0.609 μg/kg bw per day, respectively, and Sirot et al. found the AA expo-
sure levels for 1–4, 5–6, 7–12 and 13–36 months-old babies as 0.14, 0.03, 0.40 and 
0.07 μg/kg bw per day, respectively [30, 73].
3.  Acrylamide, furan and chloropropanol exposure caused  
by breast milk
It is estimated that babies are exposed to contaminants coming from breast milk 
from the first seconds of their lives. This exposure varies depending on the impact 
of many factors such as the age of the mother, dietary habits, living space, and envi-
ronmental contaminants etc. on the compounds in breast milk. Therefore, breast 
milk is globally monitored as a biomarker for exposure and sheds light on exposure 
evaluation studies [74, 75].
The number of studies on the acrylamide level of breast milk is very limited. 
Sörgel et al. detected acrylamide in milk of mothers consuming foods that contain 
high levels of acrylamide such as potato chips, French fries etc. They stated that 10 
to 50% of acrylamide occurring in pregnant women due to nutrition is transferred 
Food groups Mean (μg/kg)
Potato fried products (except potato crisps and snacks) 308 (303–313)
Potato crisps and snacks 389 (388–389)
Soft bread 42 (36–49)
Breakfast cereals 161 (157–164)
Biscuits, crackers, crisp bread and similar 265 (261–269)
Coffee (dry) 522 (521–523)
Coffee substitutes (dry) 1499
Baby foods, other than cereal-based 24 (17–31)
Processed cereal-based baby foods 73 (70–76)
Other products based on potatoes, cereals and cocoa 97 (92–101)
*The data were taken directly from EFSA Journal.
Table 5. 
AA the mean levels of several foods (μg/kg) [69].
Age group Mean dietary exposure  
(μg/kg bw per day)
High dietary exposure  
(μg/kg bw per day)
Infants 0.5–1.6 1.4–2.5
Toddlers 0.9–1.9 1.4–3.4
Other children 0.9–1.6 1.4–3.2
Adolescents 0.4–0.9 0.9–2.0
Adults 0.4–0.6 0.8–1.3
Elderly 0.4–0.5 0.7–1.0
Very elderly 0.4–0.5 0.6–1.0
*The data were taken directly from EFSA Journal.
Table 6. 
The mean of the dietary AA exposure [69].
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to the fetus through blood and it can reach μg/L in breast milk. They state that 
acrylamide exposure caused by breast milk continues until the end of breastfeed-
ing, and therefore nursing mothers should avoid foods containing acrylamide until 
uncertainties about acrylamide are eliminated [76]. Fohgelberg et al. stated that 
traces of acrylamide were detected in all breast milk samples, the acrylamide level 
was determined as 0.51 μg/kg only in one sample while the acrylamide levels in 
the other 18 samples were under the limit of quantification (0.5 μg/kg). The mean 
acrylamide level in breast milk was assumed to be 0.25 μg/kg in the study and the 
mean acrylamide exposure was estimated as 0.04 μg/kg bw per day (the mean body 
weight is calculated as 5.5 kg) for infants that are fed only with breast milk during 
the early breastfeeding period. The results revealed the importance of breastfeeding 
as a way of preventing the baby from being exposed to acrylamide as the level of 
acrylamide in breast milk is very low [70].
The source and possible consequences of 3-MCPD in breast milk have not been 
entirely explored yet. However, it has been stated that dietary habits of mothers are 
an important factor for presence of 3-MCPD in breast milk [34, 77]. Zelinkova et al. 
determined the 3-MCPD level between 11 and 76 μg/kg and the mean amount as 
35.5 μg/kg in 12 breast milk samples. They determined the 3-MCPD exposure caused 
by breast milk in babies (breastfed for up to 4 months) as 26,625 μg/day (average 
daily intake of mother’s milk by the baby is about 750 mL) and 8.19 μg/kg bw per day 
[77]. Jędrkiewicz et al. stated that 2-MCPD and 3-MCPD reached 2.2 mg/kg in breast 
milk and therefore it was highly difficult for babies to avoid chloropropanols [78].
Polychlorinated dibenzofurans (PCDFs), which are another contaminant in breast 
milk, have been examined in studies together with polychlorinated biphenyls (PCBs) 
and polychlorinated dibenzo-p-dioxins (PCDDs). A lot of studies can be found in 
the literature on this subject compared to acrylamide and chloropropanols. As breast 
milk is the first and most important way of conveying PCBs and PCDD/Fs to babies, 
WHO has been conducting global studies on dioxin detection in breast milk since 1987 
[79]. Costopoulou et al. reported that the countries with the highest level of PCBs and 
PCDD/Fs in breast milk are Egypt, the Netherlands, Belgium, Luxemburg, and Italy 
{respectively, 22.3, 18.27, 16.92, 14.97, 12.66 pg/g [fat WHO-TEQ (toxicity equivalent)]} 
while the countries with the lowest levels are Fiji, Brazil, the Philippines, Australia, and 
Bulgaria (respectively 3.34, 3.92, 3.94, 5.57 and 6.14 pg/g fat WHO-TEQ) [80]. WHO 
has estimated the range of tolerable daily dose as 1–4 pg TEQ/kg bs per day for babies 
exposed to dioxin contaminants such as PCDD/Fs and PCBs [81]. Focant et al. calcu-
lated the average concentration for total TEQ (PCDD/Fs and PCBs) as 17.81 pg/g and 
the daily intake of PCDD/Fs and PCBs as 62.3 TEQ/kg bw per day [82]. In a study they 
conducted in China (Guangdong Province), Huang et al. predicted the mean EDI level 
of PCDD/PCBs resulting from breast milk as 54.3 pg TEQ/kg bw per day [83].
4. Conclusion
The current review evaluated infant formulas that have an important place in 
the diets of babies, with respect to the thermal processing contaminants; furan, 
chloropropanols and acrylamide, which have become one of the foci of researchers. 
When the results of the studies regarding the exposure of these contaminants are 
evaluated, it is suggested that babies are in the risk group, who are highly exposed to 
these contaminants because of their low body weight compared to other individu-
als, besides; there are no alternative foods to infant formulas in their daily diet. 
In the light of the evidence revealed by the previous studies, the current review 
proposes that regarding the furan, chloropropanols and acrylamide, infant formulas 
can be a concern for baby health. Nevertheless, the review further suggests that it is 
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important to decrease the level of thermal processing contaminants or specify cer-
tain upper limits and determine these regulations by law for the individual health 
and the health of the overall society. Furthermore, the current review emphasized 
that infant formulas are not alternatives to breast milk and educating mothers in 
this respect is critically important for the health of next generations. One last thing 
to emphasize is the need to raise the awareness of breastfeeding mothers in avoiding 
the consumption of foods that have a rich content in terms of the abovementioned 
contaminants.
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